Developer docs
API playgroundTry for free, no card

Search company profiles

Maypo

Full company profile

uuid0038lel

Namestring
Maypo
Legal namestring
Farmacéuticos Maypo, S.A. de C.V.
Websiteurl
maypo.com
Company typeenum
Private
Founded yearint
1960
Descriptiontext

Maypo is a Mexico City-headquartered pharmaceutical distribution and fourth-party logistics (4PL) company specializing in high-specialty medicines and cold chain products. Founded in 1993 by the Arenas family and operating for 30+ years, the company serves Mexican government health institutions — including ISSSTE (850+ hospitals, 150M+ units annually), PEMEX, SSA, IMSS, and INCAN — as well as 30+ transnational pharmaceutical companies via its Vanguardia business model. Core operations are anchored by Campus Maypo, a 90,000 m³ automated logistics center (described as the most modern in Latin America), featuring Multishuttle equipment, Voice Picking systems, SAP ERP, and computerized temperature/humidity monitoring, supporting 12-24 hour nationwide cold-chain delivery.

The company generates revenue through managed distribution, storage, and dispensing services (Logistics, Distribution, Importación, Asuntos Regulatorios), supplemented by higher-value specialized services including pharmaceutical compounding (Central de Mezclas), business intelligence (Maypo Insights 2.0 platform), and strategic partner services (SEA). Pricing is via custom B2B contracts with healthcare institutions and pharmaceutical laboratories — no public pricing is disclosed. Maypo holds COFEPRIS sanitary licenses for controlled drugs (Classes I, II, III) and biologicals, ISO 9001:2015 cold chain certification, and GMP compliance. Go-to-market is sales-led enterprise field sales with dedicated account managers for hospital/institution clients and laboratory/commercial partners. The company remains family-owned (Arenas family) with no external institutional investment or public listing, operating exclusively in Mexico with no disclosed international expansion.

Short descriptiontext

Maypo is a Mexico-based pharmaceutical 4PL distributor specializing in cold chain and high-specialty medicines, serving Mexican government health institutions (ISSSTE, PEMEX, SSA, IMSS) and 30+ transnational pharma companies through its automated Campus Maypo logistics center.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersCoyoacán, Mexico
HQ citystring
Coyoacán
HQ countrystring
Mexico
HQ regionstring
Latin America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical distribution, cold chain logistics, high specialty medicines, pharmaceutical 4PL services, healthcare supply chain
Industry4 codes
PRIMARYHLAIAJAL
Third-Party Logistics (3PL) & Warehousing for Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYTLAIABAA
4PL / Lead Logistics Provider (LLP) & Control Tower
SECONDARYTLAIAAAL
Industry-Specific Contract Logistics (Automotive, Pharma, Retail, Aerospace, etc.)
SECONDARYTLAIABAF
Exception Management, Track & Trace & Visibility Operations (SLA/KPI Governance)
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Distribution & Cold Chain Logistics
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model6 records
1Pharmaceutical Distribution Services
TypeManaged Services
Description

Core distribution, storage, dispensing, and commercialization services for medications of high specialty and cold chain products, serving pharmaceutical industry and healthcare sector

maypo.com
2Logistics Services (4PL)
TypeManaged Services
Description

Fourth-party logistics provider specializing in cold chain, high specialty products, clinical protocols and operational processes for pharmaceutical industry

maypo.com
3Distribution Services
TypeTransaction Fee
Description

Air and ground distribution services for medications with cold chain requirements, ensuring 12-24 hour delivery nationwide

maypo.com
4Import Services
TypeProfessional Services
Description

Import support for pharmaceutical products including acquisition follow-up, manufacturer contact, and regulatory compliance for laboratories

maypo.com
5Regulatory Affairs
TypeProfessional Services
Description

Compliance and quality management services for logistics processes including ISO certifications and COFEPRIS licensing

maypo.com
6Business Intelligence
TypeSubscription Recurring
Description

Strategic additional services (SEA) providing added value to business partners through data and insights

maypo.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1Vanguardia
Description

Business model created in 2019 serving transnational pharmaceutical companies with innovative logistics services.

maypo.com
+2 more records
Core offering1 text field

Maypo is a Mexican pharmaceutical fourth-party logistics (4PL) provider that distributes, stores, and commercializes high-specialty and cold chain medicines on behalf of pharmaceutical laboratories and healthcare institutions. Its offering spans 4PL logistics, air and ground cold chain distribution with 12-24 hour nationwide delivery, import support for foreign manufacturers, regulatory affairs under COFEPRIS and ISO 9001:2015 frameworks, pharmaceutical compounding (Central de Mezclas), business intelligence, and the Vanguard model serving 30+ transnational pharmaceutical companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 850+ hospitals served with 150+ million units annually for ISSSTE
+3 more records
Product overview1 text field

Maypo is a pharmaceutical distribution company offering an integrated suite of logistics and supply chain services for the healthcare industry. The core offering consists of 4PL logistics services specializing in cold chain management and high-specialty medicines, complemented by air and ground distribution with 12-24 hour delivery times, import services for pharmaceutical products, and regulatory affairs support. The portfolio includes specialized services such as the Vanguard innovative business model, Central de Mezclas for pharmaceutical compounding, and the Maypo Insights digital platform for real-time order tracking. The company operates as a 4PL (Fourth-Party Logistics) provider with advanced automation infrastructure including Multishuttle systems and SAP ERP.

Product and service9 records
1Logística (4PL Logistics)
CategoryPharmaceutical 4PL Logistics
Description

4PL logistics service specializing in Cold Chain Network, high specialty products, clinical protocols, and operational processes aligned with the pharmaceutical industry, complying with GMP standards and sanitary storage requirements.

2Distribución (Distribution)
CategoryCold Chain Pharmaceutical Distribution
Description

Transport of medicines in cold chain with specialized protocols and transport units; air and ground distribution with delivery times of 12 to 24 hours throughout Mexico.

3Importación (Imports)
CategoryPharmaceutical Import Services
Description

Assists pharmaceutical laboratories with importing pharmaceutical products, including acquisition follow-up, contacting foreign manufacturers, and advising on requirements from governmental entities, customs authorities, and sanitary control agencies.

4Asuntos Regulatorios (Regulatory Affairs)
CategoryRegulatory Affairs & Compliance
Description

Quality management systems aligned with ISO 9001:2015 for logistics processes, including compliance with COFEPRIS operating licenses and good storage and distribution practices.

5Vanguard (Vanguardia)
CategoryPharmaceutical Services Business Model
Description

Innovative business model launched in 2019, recognized by the transnational pharmaceutical industry as innovative, providing service to over 30 pharmaceutical companies with tailored distribution and commercialization offerings.

6Central de Mezclas (Mixing Center)
CategoryPharmaceutical Compounding Services
Description

Pharmaceutical compounding service for customized medication preparation.

7Inteligencia de Negocios (Business Intelligence)
CategoryBusiness Intelligence & Analytics Services
Description

Business intelligence services providing data analysis and insights for operational decision-making.

8Unidad de Servicios Logísticos (USL)
CategoryLogistics Services Unit
Description

Logistical services unit created in 2009 to provide specialized logistics support.

9Maypo Insights (platform v2.0)
CategoryOrder Tracking & Visibility Platform
Description

Real-time tracking platform launched in 2023 that allows viewing of order process from receipt to delivery/collection, with version 2.0 introducing enhanced visibility and stakeholder access.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global contract logistics provider with a Healthcare vertical offering pharma cold chain warehousing and distribution. Comparable service portfolio to Maypo's 4PL offering and increasingly active in Latin America.

2McKesson Corporation
TypeBroad incumbent
Description

Global pharmaceutical distributor and wholesaler with operations across North America. Represents the multinational incumbent that Maypo's Vanguardia unit competes against for transnational pharma contracts in Mexico.

3UPS Healthcare
TypeEmerging player
Description

Global logistics and supply chain operator with a growing healthcare vertical focused on cold chain pharma distribution, cold storage, and clinical trial logistics. Overlaps with Maypo's cold chain 4PL focus and represents the kind of well-capitalized entrant Maypo must defend against.

TypeBroad incumbent
Description

One of the largest global pharmaceutical distribution and consulting services companies. Direct competitor for high-value specialty pharma distribution contracts in Latin America and a benchmark for what scale logistics looks like.

5Dimesa (Distribuidora Internacional de Medicamentos)
TypeDirect peer
Description

Major Mexican pharmaceutical distributor serving government institutions (IMSS, ISSSTE) and private pharmacies with national coverage. Closely mirrors Maypo's mix of public-sector contract logistics and pharmaceutical wholesale.

6Grupo Casa Saba
TypeDirect peer
Description

One of the largest Mexican pharmaceutical distributors, providing wholesale distribution and specialized logistics services to pharmacies, hospitals, and government health institutions — directly comparable to Maypo in customer base (Mexican health sector) and business model (pharma wholesale/3PL).

TypeBroad incumbent
Description

Global contract logistics provider with a dedicated Life Sciences & Healthcare division offering cold chain pharma warehousing and distribution. Comparable to Maypo's 4PL cold chain offering but at vastly greater geographic and capital scale.

TypeDirect peer
Description

Mexican pharmaceutical wholesaler distributing drugs and druggists' sundries to pharmacies and institutions. Directly comparable on wholesale pharma distribution and customer base.

TypeDirect peer
Description

Mexican pharmaceutical distributor with national reach, serving retail pharmacies and healthcare institutions. Comparable to Maypo in product category, customer overlap, and distribution-driven B2B model.

TypeBroad incumbent
Description

Global logistics provider with a dedicated pharma & healthcare vertical (KN PharmaChain) covering cold chain airfreight, warehousing, and distribution. Competes for the same multinational pharma clients that Maypo's Vanguardia targets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights2 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Maypo

Pharmaceutical Distribution & Cold Chain Logisticsmaypo.com

Maypo is a Mexico-based pharmaceutical 4PL distributor specializing in cold chain and high-specialty medicines, serving Mexican government health institutions (ISSSTE, PEMEX, SSA, IMSS) and 30+ transnational pharma companies through its automated Campus Maypo logistics center.

What Maypo does

Maypo is a Mexico City-headquartered pharmaceutical distribution and fourth-party logistics (4PL) company specializing in high-specialty medicines and cold chain products. Founded in 1993 by the Arenas family and operating for 30+ years, the company serves Mexican government health institutions — including ISSSTE (850+ hospitals, 150M+ units annually), PEMEX, SSA, IMSS, and INCAN — as well as 30+ transnational pharmaceutical companies via its Vanguardia business model. Core operations are anchored by Campus Maypo, a 90,000 m³ automated logistics center (described as the most modern in Latin America), featuring Multishuttle equipment, Voice Picking systems, SAP ERP, and computerized temperature/humidity monitoring, supporting 12-24 hour nationwide cold-chain delivery.

The company generates revenue through managed distribution, storage, and dispensing services (Logistics, Distribution, Importación, Asuntos Regulatorios), supplemented by higher-value specialized services including pharmaceutical compounding (Central de Mezclas), business intelligence (Maypo Insights 2.0 platform), and strategic partner services (SEA). Pricing is via custom B2B contracts with healthcare institutions and pharmaceutical laboratories — no public pricing is disclosed. Maypo holds COFEPRIS sanitary licenses for controlled drugs (Classes I, II, III) and biologicals, ISO 9001:2015 cold chain certification, and GMP compliance. Go-to-market is sales-led enterprise field sales with dedicated account managers for hospital/institution clients and laboratory/commercial partners. The company remains family-owned (Arenas family) with no external institutional investment or public listing, operating exclusively in Mexico with no disclosed international expansion.

Maypo firmographics

Firmographics
Name
Maypo
Legal name
Farmacéuticos Maypo, S.A. de C.V.
Website
https://maypo.com
Company type
Private
Founded year
1960
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Maypo is a Mexico-based pharmaceutical 4PL distributor specializing in cold chain and high-specialty medicines, serving Mexican government health institutions (ISSSTE, PEMEX, SSA, IMSS) and 30+ transnational pharma companies through its automated Campus Maypo logistics center.
Ownership category
akta.pro rank

Maypo industry classification

Industry
Product category
Pharmaceutical Distribution & Cold Chain Logistics
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAJAL
Third-Party Logistics (3PL) & Warehousing for Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYTLAIABAA
4PL / Lead Logistics Provider (LLP) & Control Tower
SECONDARYTLAIAAAL
Industry-Specific Contract Logistics (Automotive, Pharma, Retail, Aerospace, etc.)
SECONDARYTLAIABAF
Exception Management, Track & Trace & Visibility Operations (SLA/KPI Governance)

Keywords

  • Pharmaceutical distribution
  • Cold chain logistics
  • High specialty medicines
  • Pharmaceutical 4PL services
  • Healthcare supply chain

Where Maypo is headquartered

Location

Headquarters

HQ city
Coyoacán
HQ country
Mexico
HQ region
Latin America

Offices5 records

Markets served

Maypo business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Pharmaceutical Distribution Services: Core distribution, storage, dispensing, and commercialization services for medications of high specialty and cold chain products, serving pharmaceutical industry and healthcare sector
  2. Logistics Services (4PL): Fourth-party logistics provider specializing in cold chain, high specialty products, clinical protocols and operational processes for pharmaceutical industry
  3. Distribution Services: Air and ground distribution services for medications with cold chain requirements, ensuring 12-24 hour delivery nationwide
  4. Import Services: Import support for pharmaceutical products including acquisition follow-up, manufacturer contact, and regulatory compliance for laboratories
  5. Regulatory Affairs: Compliance and quality management services for logistics processes including ISO certifications and COFEPRIS licensing
  6. Business Intelligence: Strategic additional services (SEA) providing added value to business partners through data and insights

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Maypo product offering

Product offering

Core offering

Maypo is a Mexican pharmaceutical fourth-party logistics (4PL) provider that distributes, stores, and commercializes high-specialty and cold chain medicines on behalf of pharmaceutical laboratories and healthcare institutions. Its offering spans 4PL logistics, air and ground cold chain distribution with 12-24 hour nationwide delivery, import support for foreign manufacturers, regulatory affairs under COFEPRIS and ISO 9001:2015 frameworks, pharmaceutical compounding (Central de Mezclas), business intelligence, and the Vanguard model serving 30+ transnational pharmaceutical companies.

Product overview

Maypo is a pharmaceutical distribution company offering an integrated suite of logistics and supply chain services for the healthcare industry. The core offering consists of 4PL logistics services specializing in cold chain management and high-specialty medicines, complemented by air and ground distribution with 12-24 hour delivery times, import services for pharmaceutical products, and regulatory affairs support. The portfolio includes specialized services such as the Vanguard innovative business model, Central de Mezclas for pharmaceutical compounding, and the Maypo Insights digital platform for real-time order tracking. The company operates as a 4PL (Fourth-Party Logistics) provider with advanced automation infrastructure including Multishuttle systems and SAP ERP.

Differentiator

Problem solved

Functional benefit

Brands

  • Vanguardia: Business model created in 2019 serving transnational pharmaceutical companies with innovative logistics services.
  • SEA (Servicios Estratégicos Adicionales)
  • Maypo Insights

Products and services

  • Logística (4PL Logistics) 4PL logistics service specializing in Cold Chain Network, high specialty products, clinical protocols, and operational processes aligned with the pharmaceutical industry, complying with GMP standards and sanitary storage requirements.
  • Distribución (Distribution) Transport of medicines in cold chain with specialized protocols and transport units; air and ground distribution with delivery times of 12 to 24 hours throughout Mexico.
  • Importación (Imports) Assists pharmaceutical laboratories with importing pharmaceutical products, including acquisition follow-up, contacting foreign manufacturers, and advising on requirements from governmental entities, customs authorities, and sanitary control agencies.
  • Asuntos Regulatorios (Regulatory Affairs) Quality management systems aligned with ISO 9001:2015 for logistics processes, including compliance with COFEPRIS operating licenses and good storage and distribution practices.
  • Vanguard (Vanguardia) Innovative business model launched in 2019, recognized by the transnational pharmaceutical industry as innovative, providing service to over 30 pharmaceutical companies with tailored distribution and commercialization offerings.
  • Central de Mezclas (Mixing Center) Pharmaceutical compounding service for customized medication preparation.
  • Inteligencia de Negocios (Business Intelligence) Business intelligence services providing data analysis and insights for operational decision-making.
  • Unidad de Servicios Logísticos (USL) Logistical services unit created in 2009 to provide specialized logistics support.
  • Maypo Insights (platform v2.0) Real-time tracking platform launched in 2023 that allows viewing of order process from receipt to delivery/collection, with version 2.0 introducing enhanced visibility and stakeholder access.

Quantifiable outcome

  • 850+ hospitals served with 150+ million units annually for ISSSTE
  • +3 more outcomes

Companies that use Maypo

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles2 records

Maypo technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Maypo partnerships and signals

Strategic signal

Scale indicators9 records

Recent moves9 records

Expansion highlights4 records

Maypo competitors and assessment

Company assessment

Broad incumbents

  • CEVA Logistics (Healthcare): Global contract logistics provider with a Healthcare vertical offering pharma cold chain warehousing and distribution. Comparable service portfolio to Maypo's 4PL offering and increasingly active in Latin America.
  • McKesson Corporation: Global pharmaceutical distributor and wholesaler with operations across North America. Represents the multinational incumbent that Maypo's Vanguardia unit competes against for transnational pharma contracts in Mexico.
  • Cencora (formerly AmerisourceBergen): One of the largest global pharmaceutical distribution and consulting services companies. Direct competitor for high-value specialty pharma distribution contracts in Latin America and a benchmark for what scale logistics looks like.
  • DHL Supply Chain (Life Sciences): Global contract logistics provider with a dedicated Life Sciences & Healthcare division offering cold chain pharma warehousing and distribution. Comparable to Maypo's 4PL cold chain offering but at vastly greater geographic and capital scale.
  • Kuehne+Nagel (KN PharmaChain): Global logistics provider with a dedicated pharma & healthcare vertical (KN PharmaChain) covering cold chain airfreight, warehousing, and distribution. Competes for the same multinational pharma clients that Maypo's Vanguardia targets.

Emerging players

  • UPS Healthcare: Global logistics and supply chain operator with a growing healthcare vertical focused on cold chain pharma distribution, cold storage, and clinical trial logistics. Overlaps with Maypo's cold chain 4PL focus and represents the kind of well-capitalized entrant Maypo must defend against.

Direct peers

  • Dimesa (Distribuidora Internacional de Medicamentos): Major Mexican pharmaceutical distributor serving government institutions (IMSS, ISSSTE) and private pharmacies with national coverage. Closely mirrors Maypo's mix of public-sector contract logistics and pharmaceutical wholesale.
  • Grupo Casa Saba: One of the largest Mexican pharmaceutical distributors, providing wholesale distribution and specialized logistics services to pharmacies, hospitals, and government health institutions — directly comparable to Maypo in customer base (Mexican health sector) and business model (pharma wholesale/3PL).
  • Droguería Internacional (DI): Mexican pharmaceutical wholesaler distributing drugs and druggists' sundries to pharmacies and institutions. Directly comparable on wholesale pharma distribution and customer base.
  • Grupo Bruluart: Mexican pharmaceutical distributor with national reach, serving retail pharmacies and healthcare institutions. Comparable to Maypo in product category, customer overlap, and distribution-driven B2B model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights2 records

Customer concentration

Maypo social profiles

Digital presence

Maypo compliance and trust

Trust signal

Compliance3 records

Maypo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Maypo leadership team

Management profile

Number of profiles

Profiles2 records

Maypo funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Maypo M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Maypo

What does Maypo do?

Maypo is a Mexican pharmaceutical fourth-party logistics (4PL) provider that distributes, stores, and commercializes high-specialty and cold chain medicines on behalf of pharmaceutical laboratories and healthcare institutions. Its offering spans 4PL logistics, air and ground cold chain distribution with 12-24 hour nationwide delivery, import support for foreign manufacturers, regulatory affairs under COFEPRIS and ISO 9001:2015 frameworks, pharmaceutical compounding (Central de Mezclas), business intelligence, and the Vanguard model serving 30+ transnational pharmaceutical companies.

Is Maypo a public or private company?

Maypo is a private company. It is classified as family owned and is currently operating.

When was Maypo founded?

Maypo was founded in 1960. It employs 501 to 1,000 people.

Where is Maypo based?

Maypo is headquartered in Coyoacán, Mexico, in the Latin America region.

How does Maypo make money?

Six revenue lines are on record. Pharmaceutical Distribution Services are the primary driver. The others are logistics Services (4PL), distribution Services, import Services, regulatory Affairs and business Intelligence.

Who are Maypo's main competitors?

Broad incumbents on record are CEVA Logistics (Healthcare), McKesson Corporation, Cencora (formerly AmerisourceBergen), DHL Supply Chain (Life Sciences) and Kuehne+Nagel (KN PharmaChain). UPS Healthcare is listed as an emerging player. Direct peers are Dimesa (Distribuidora Internacional de Medicamentos), Grupo Casa Saba, Droguería Internacional (DI) and Grupo Bruluart.

Does Maypo have an API?

No public API is recorded for Maypo.

What industry is Maypo in?

Maypo's product category is Pharmaceutical Distribution & Cold Chain Logistics. Its primary akta.pro industry code is HLAIAJAL, Third-Party Logistics (3PL) & Warehousing for Pharmaceuticals, with a secondary code of TLAIABAA, 4PL / Lead Logistics Provider (LLP) & Control Tower. Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales